The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes (the CHEC-SC study)
This study will collect contemporary sweat chloride values from cystic fibrosis patients prescribed and currently receiving commercially approved CFTR modulator therapies.
This is a multicenter, cross-sectional, cohort study which will collect contemporary SC values from approximately 1000 CF patients prescribed and currently receiving commercially approved CFTR modulator therapies.
Participants will not be paid for their participation.
- IRB Number: 1712442067
- Research Study Identifier: TX9262
- Principal Investigator: Clement Ren, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required